Laurus Labs Ltd. (LAURUSLABS) Share Price Hits Fresh 52-Week High

Laurus Labs Ltd. Share Price reached a fresh 52-week high of Rs 1,800, rising 1% today. The market cap stands at Rs 96,264.73 crore.

Laurus Labs Ltd. Share Price has reached a fresh 52-week high of Rs 1,800, marking a 1% increase from the previous close of Rs 1,781.4. The stock opened at Rs 1,785.05 and reached a high of Rs 1,800 during the trading session. With a market capitalisation of Rs 96,264.73 crore, Laurus Labs Ltd. is attracting significant attention in the market. The rise in share price highlights investor interest, although no specific catalyst has been identified in the data provided. Univest continues to monitor the stock for further developments.

Laurus Labs Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,799.2
Previous Close	Rs 1,781.4
Today's Change	+Rs 17.8 (+1%)
Day Open	Rs 1,785.05
Fresh 52-Week High	Rs 1,800
Day Low	Rs 1,785.05
Current Volume	7,602
Turnover	Rs 1.37 crore
Market Capitalisation	Rs 96,264.73 crore

Laurus Labs Ltd. (LAURUSLABS) traded at Rs 1,799.2. versus the previous close of Rs 1,781.4, a rise of 1%. The stock opened at Rs 1,785.05, reached Rs 1,800, touched Rs 1,785.05. Reported volume was 7,602.

Today, Laurus Labs Ltd. Share Price opened at Rs 1,785.05 and quickly climbed to a fresh 52-week high of Rs 1,800. The stock closed at Rs 1,799.2, reflecting a 1% increase from the previous close of Rs 1,781.4. The day's low was also Rs 1,785.05, indicating a strong upward movement throughout the session. The turnover for the day was Rs 1.37 crore with a volume of 7,602 shares, suggesting moderate trading activity. This price action underscores the stock's momentum, drawing attention from investors.

Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 96,264.73 crore
P/E Ratio	39.17x
P/B Ratio	7.93x
ROE	28.21%
ROCE	26.35%

Laurus Labs Ltd. was valued at a P/E ratio of 39.17x, a P/B ratio of 7.93x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	39.17x
Benchmark Median P/E	20.13x
Benchmark Average P/E	73.73x
Benchmark P/E Range	0x to 3,417.8x
Company P/B Ratio	7.93x
Benchmark Median P/B	1.92x
Company ROE	28.21%
Benchmark Median ROE	10.73%
Company ROCE	26.35%
Benchmark Median ROCE	13.2%
Company Market Capitalisation	Rs 96,264.73 crore
Benchmark Median Market Cap	Rs 140.91 crore

Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare.

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 39.17x, which is above the benchmark median of 20.13x, a difference of +94.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Laurus Labs Ltd. (LAURUSLABS) has a ROE of 28.21%, which is above the benchmark median of 10.73%, a difference of +162.91%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 26.35%, which is above the benchmark median of 13.2%, a difference of +99.62%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Kwality Pharmaceuticals Ltd.	KPL	2,700.98	39.17	7.93	28.21	26.35
Beta Drugs Ltd.	BETA	2,475.7	58.88	9.32	18.65	22.17
Sai Parenteral's Ltd.	SAIPARENT	2,439.14	165.82	3.06	13.9	12.97
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,424.44	34.59	7	-2.6	16.92
Venus Remedies Ltd.	VENUSREM-BE	2,150.28	17.79	3.01	9.85	7.89

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 39.17x compared with the displayed peer median of 39.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 96,264.73 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Laurus Labs Ltd.

• Fresh 52-week high at Rs 1,800, indicating strong price momentum.
• Robust fundamentals with high ROE and ROCE.
• Premium valuation compared to sector median.
• Significant market capitalisation within the Healthcare sector.

About Laurus Labs Ltd.

Laurus Labs Ltd. is a prominent player in the Healthcare sector, focusing on the development and manufacturing of pharmaceutical products. The company operates across various segments, including active pharmaceutical ingredients (APIs), formulations, and biotechnology. With a strong emphasis on research and development, Laurus Labs Ltd. has established itself as a leader in the industry, catering to both domestic and international markets. The company's strategic initiatives and robust product portfolio contribute to its competitive edge in the pharmaceutical landscape.

Track Laurus Labs Ltd. Share Price on Univest

Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track Laurus Labs Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest. Stay informed with the latest data and analysis to make well-informed investment decisions.

Frequently Asked Questions

What is the current share price of Laurus Labs Ltd.?

Ans. The current share price of Laurus Labs Ltd. is Rs 1,799.2, marking a 1% increase from the previous close of Rs 1,781.4. The stock moved 1% during the session. The intraday range extended from Rs 1,785.05 to Rs 1,800.

What is the market capitalisation of Laurus Labs Ltd.?

Ans. Laurus Labs Ltd. has a market capitalisation of Rs 96,264.73 crore, positioning it as a major player in the Healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 39.17x.

What is Laurus Labs Ltd.'s P/E ratio?

Ans. Laurus Labs Ltd.'s P/E ratio is 39.17, which is above the sector median of 20.13, indicating a premium valuation. The company trades at a P/E ratio of 39.17x. Its P/B ratio is 7.93x.

How does Laurus Labs Ltd.'s ROE compare to the sector?

Ans. Laurus Labs Ltd.'s ROE of 28.21% is significantly higher than the sector median of 10.73%, showcasing strong profitability. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.

What is Laurus Labs Ltd.'s ROCE?

Ans. Laurus Labs Ltd.'s ROCE is 26.35%, well above the sector median of 13.2%, indicating efficient capital use. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.

Who are Laurus Labs Ltd.'s peers?

Ans. Laurus Labs Ltd.'s peers include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., and Sai Parenteral's Ltd., among others in the Healthcare sector. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Sai Parenteral's Ltd.

What is the sector P/E median?

Ans. The sector P/E median is 20.13, with Laurus Labs Ltd. having a higher P/E ratio of 39.17. The company trades at a P/E ratio of 39.17x. Its P/B ratio is 7.93x.

What is the sector ROE median?

Ans. The sector ROE median is 10.73%, while Laurus Labs Ltd. has a higher ROE of 28.21%. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.

How does Laurus Labs Ltd.'s market cap compare to its peers?

Ans. Laurus Labs Ltd.'s market cap of Rs 96,264.73 crore is significantly larger than its listed peers, highlighting its major presence in the sector. The company operates in the Healthcare sector.